These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20551012)

  • 1. Homocysteinethiolactone and paraoxonase: novel markers of diabetic retinopathy.
    Barathi S; Angayarkanni N; Pasupathi A; Natarajan SK; Pukraj R; Dhupper M; Velpandian T; Muralidharan C; Sivashanmugham M
    Diabetes Care; 2010 Sep; 33(9):2031-7. PubMed ID: 20551012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Paraoxonase activity in relation to lipid profile in Age-related Macular Degeneration patients.
    AnandBabu K; Bharathidevi SR; Sripriya S; Sen P; Prakash VJ; Bindu A; Viswanathan N; Angayarkanni N
    Exp Eye Res; 2016 Nov; 152():100-112. PubMed ID: 27693409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular distribution of antioxidant enzyme paraoxonase & its alteration in cataractous lens & diabetic retina.
    Bharathidevi SR; Babu KA; Jain N; Muthukumaran S; Umashankar V; Biswas J; Angayarkanni N
    Indian J Med Res; 2017 Apr; 145(4):513-520. PubMed ID: 28862184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine levels in the vitreous of proliferative diabetic retinopathy and rhegmatogenous retinal detachment: its modulating role on lysyl oxidase.
    Coral K; Angayarkanni N; Gomathy N; Bharathselvi M; Pukhraj R; Rupak R
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3607-12. PubMed ID: 19369240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human valacyclovir hydrolase/biphenyl hydrolase-like protein is a highly efficient homocysteine thiolactonase.
    Marsillach J; Suzuki SM; Richter RJ; McDonald MG; Rademacher PM; MacCoss MJ; Hsieh EJ; Rettie AE; Furlong CE
    PLoS One; 2014; 9(10):e110054. PubMed ID: 25333274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free amino acids hydroxyproline, lysine, and glycine promote differentiation of retinal pericytes to adipocytes: A protective role against proliferative diabetic retinopathy.
    Vidhya S; Ramya R; Coral K; Sulochana KN; Bharathidevi SR
    Exp Eye Res; 2018 Aug; 173():179-187. PubMed ID: 29752946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.
    Lakshman MR; Gottipati CS; Narasimhan SJ; Munoz J; Marmillot P; Nylen ES
    Metabolism; 2006 Sep; 55(9):1201-6. PubMed ID: 16919539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
    Deng J; Wu DZ; Gao R
    Yan Ke Xue Bao; 1999 Mar; 15(1):17-21. PubMed ID: 12579655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy.
    Zheng B; Li T; Chen H; Xu X; Zheng Z
    Am J Ophthalmol; 2011 Dec; 152(6):1039-43. PubMed ID: 21851923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of retinal laser photocoagulation on the activity of metalloproteinases and the alpha(2)-macroglobulin proteolytic state in the vitreous of eyes with proliferative diabetic retinopathy.
    Sánchez MC; Luna JD; Barcelona PF; Gramajo AL; Juarez PC; Riera CM; Chiabrando GA
    Exp Eye Res; 2007 Nov; 85(5):644-50. PubMed ID: 17826767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative diabetic retinopathy and relations among antioxidant activity, oxidative stress, and VEGF in the vitreous body.
    Izuta H; Matsunaga N; Shimazawa M; Sugiyama T; Ikeda T; Hara H
    Mol Vis; 2010 Jan; 16():130-6. PubMed ID: 20142849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible involvement of endothelin-1 and nitric oxide in the pathogenesis of proliferative diabetic retinopathy.
    Oku H; Kida T; Sugiyama T; Hamada J; Sato B; Ikeda T
    Retina; 2001; 21(6):647-51. PubMed ID: 11756889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
    Ambati J; Chalam KV; Chawla DK; D'Angio CT; Guillet EG; Rose SJ; Vanderlinde RE; Ambati BK
    Arch Ophthalmol; 1997 Sep; 115(9):1161-6. PubMed ID: 9298058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Activating Transcription Factor 4 and Glucose-Regulated 78 Kda Protein Levels Correlate with Inflammatory Cytokines in the Aqueous Humor and Vitreous of Proliferative Diabetic Retinopathy.
    Wang Y; Gao S; Zhu Y; Shen X
    Curr Eye Res; 2017 Aug; 42(8):1202-1208. PubMed ID: 28497987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of homocysteine thiolactone on paraoxonase and aryl esterase activity of human serum purified paraoxonase 1 in vitro experiments.
    Moshtaghie E; Nayeri H; Moshtaghie AA; Asgary S
    ARYA Atheroscler; 2022 Mar; 18(2):1-6. PubMed ID: 36819838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
    Itakura H; Kishi S; Kotajima N; Murakami M
    Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of chemokines and growth factors in proliferative diabetic retinopathy vitreous.
    Dai Y; Wu Z; Wang F; Zhang Z; Yu M
    Biomed Res Int; 2014; 2014():486386. PubMed ID: 25401103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High vitreous concentration of IL-6 and IL-8, but not of adhesion molecules in relation to plasma concentrations in proliferative diabetic retinopathy.
    Koskela UE; Kuusisto SM; Nissinen AE; Savolainen MJ; Liinamaa MJ
    Ophthalmic Res; 2013; 49(2):108-14. PubMed ID: 23257933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocyte chemotactic protein-1 in the vitreous of patients with proliferative diabetic retinopathy.
    Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
    Ophthalmologica; 2001; 215(6):415-8. PubMed ID: 11741107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.